XML 80 R67.htm IDEA: XBRL DOCUMENT v3.24.0.1
Earnings Per Share - Reconciliation of Numerator and Denominator of Basic and Diluted Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Numerator:      
Net loss attributable to Surgery Partners, Inc. $ (11.9) $ (54.6) $ (70.9)
Less: amounts allocated to participating securities 0.0 0.0 (10.3)
Net loss attributable to common stockholders (11.9) (54.6) (81.2)
Net loss attributable to common stockholders (diluted) $ (11.9) $ (54.6) $ (81.2)
Weighted average common shares outstanding:      
Basic (shares) 125,613 91,952 72,427
Diluted (shares) [1] 125,613 91,952 72,427
Net loss per share attributable to common stockholders:      
Basic (in USD per share) $ (0.09) $ (0.59) $ (1.12)
Diluted (in USD per share) [1] $ (0.09) $ (0.59) $ (1.12)
Stock options      
Net loss per share attributable to common stockholders:      
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 1,246 1,459 1,920
Restricted shares      
Net loss per share attributable to common stockholders:      
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 263 679 1,452
[1] The impact of potentially dilutive securities for all periods were not considered because the effect would be anti-dilutive.